Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 3551-55-1 | MDL No. : | MFCD00056028 |
Formula : | C6H8N2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | KEVRHVMWBKFGLO-UHFFFAOYSA-N |
M.W : | 140.14 | Pubchem ID : | 137976 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 35.02 |
TPSA : | 44.24 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.37 cm/s |
Log Po/w (iLOGP) : | 2.0 |
Log Po/w (XLOGP3) : | 1.11 |
Log Po/w (WLOGP) : | 0.49 |
Log Po/w (MLOGP) : | -0.52 |
Log Po/w (SILICOS-IT) : | 0.85 |
Consensus Log Po/w : | 0.79 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.72 |
Solubility : | 2.67 mg/ml ; 0.019 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.63 |
Solubility : | 3.27 mg/ml ; 0.0233 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.88 |
Solubility : | 1.84 mg/ml ; 0.0132 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.98 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; sodium tetrahydroborate; N,N,N,N,-tetramethylethylenediamine In tetrahydrofuran at 25℃; for 7 h; Inert atmosphere | General procedure: PdCl2(dppf), PdCl2(tbpf) and (A.caPhos)PdCl2. A mixture of the halogenated heterocycle (0.66 mmol) in anhydrous THF (13.2 mL) was degassed by bubbling argon for few minutes. Then, PdCl2(dppf) (27.0 mg, 0.033 mmol, 5.0 molpercent), TMEDA (0.130 g, 1.12 mmol, 1.7 equiv) and finally NaBH4 (42.4 mg, 1.12 mmol, 1.7 equiv) were introduced in sequence. The mixture was stirred at room temperature under argon for the proper time and then worked up as described above. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
36% | Stage #1: With magnesium; ethylene dibromide In tetrahydrofuran for 3 h; Reflux; Inert atmosphere Stage #2: at -10 - 20℃; Inert atmosphere Stage #3: With ammonia; copper diacetate In 1,4-dioxane; dichloromethane; water at 20℃; for 24 h; |
(CH2)2Br2 was added in 5 portions (60 μl per 30 min, 3.5 mmol) to a refluxed mixture of 8 (500 mg, 2.3 mmol), Mg (168 mg, 6.9 mmol) and dry THF (10 mL) under argon. When 8 had disappeared (TLC, hexane; after ca. 3 h), the mixture was cooled to -10 °C and compound 3 (339 mg, 1.5 mmol) was added. After stirring for 2 h at -10 °C, the mixture was allowed to warm to room temperature, stirred overnight and filtered through a Celite.(R). pad. The filtrate was concentrated to dryness. The residue was treated with Cu(OAc)2/NH3 (aq) under the conditions described in Ref. 28. Column chromatography (CHCl3/acetone, 85/15, v/v) gave 10 (126 mg, 39percent) and 11 (197 mg, 36percent, mp 151-152 °C). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
39% | Stage #1: With tert.-butyl lithium In tetrahydrofuran; pentane at -78℃; for 0.5 h; Inert atmosphere Stage #2: at -78 - 20℃; Inert atmosphere Stage #3: With ammonia; copper diacetate In 1,4-dioxane; dichloromethane; water at 20℃; for 24 h; |
t-BuLi (Aldrich; 1.7 M soln in pentane, 1.1 mL) was added to a mixture of 8 (Aldrich; 200 mg, 0.9 mmol) and dry THF (2 mL) at -78 °C under argon. The mixture was left at -78 °C for 30 min and then compound 3 (190 mg, 0.8 mmol) was added. The mixture was allowed to warm to room temperature. The reaction was followed by TLC (CHCl3/acetone, 85/15, v/v) at 30 min intervals. After stirring for 3 h at room temperature, when 3 was no longer detected by TLC, Et2O (20 mL) was added. The mixture was washed with H2O (5 mL) and evaporated to dryness. The residue was dissolved in 1,4-dioxane (6 mL) and CH2Cl2 (2 mL). Cu(OAc)2 (40 mg), NH3 (aq) (0.3 mL) and H2O (1 mL) were added. The mixture was stirred at room temperature for 1 d. The organic layer was separated, washed with H2O (10 mL), dried (MgSO4) and concentrated to dryness. Column chromatography of the residue (CHCl3/acetone, 85/15, v/v) gave 9 (70 mg, 39percent), 10 (89 mg, 71percent), and 11 (50 mg, 17percent). 9: A white solid (mp >180 °C, dec). δH (CDCl3, 200 MHz) 1.43-1.56 (16H, m), 1.90 (4H, m), 2.35 (4H, m), 3.29 (4H, m), 3.56 and 4.34 (8H, AB quartet, 2JAB 11.4 Hz); δC (CDCl3, 50 MHz) 22.34, 22.58, 25.42, 26.16, 27.48, 28.49, 36.98, 64.28, 66.43, 72.57, 98.80, 136.38; νmax (KBr) 2936, 2860, 1496, 1448, 1380, 1240, 1156, 1044, 920; HRMS (EI, 70 eV) m/z calcd for C24H36O6N2 (M+) 448.2573, found 448.2557. 11: A white solid (mp 151-152 °C). δH (CDCl3, 200 MHz) 1.34-1.84 (8H, m), 2.1 (2H, m), 2.39 (2H, m), 3.12 (2H, m), 3.63 and 4.57 (4H, AB quartet, 2JAB 11.4), 4.00 (3H, s), 4.02 (3H, s), 10.09 (1H, s); δC (CDCl3, 50 MHz) 22.39, 22.67, 25.49, 27.42, 28.21, 28.84, 37.29, 54.21, 55.19, 64.36, 72.23, 98.77, 105.98, 136.72, 159.26, 165.04, 167.74; νmax (KBr) 2948, 2936, 1716, 1688, 1556, 1536, 1480, 1464, 1356, 1252, 1244, 1108; HRMS (EI, 70 eV) m/z calcd for C18H25O5N3 (M+) 363.1794, found 363.1812. The NMR spectra of 10 were consistent with those described: H. Pelissier, J. Rodriguez and K.P.C. Volhardt, Chem. Eur. J. 5 (1999), p. 3549. Full Text via CrossRef | View Record in Scopus | Cited By in Scopus (27) |
[ 186435-66-5 ]
6-Amino-2-methoxypyrimidin-4-ol
Similarity: 0.85
[ 60186-89-2 ]
4-Bromo-2,6-dimethoxypyrimidine
Similarity: 0.83
[ 120129-83-1 ]
2,4-Dimethoxy-5,6-dimethylpyrimidine
Similarity: 0.80
[ 6320-15-6 ]
4-Chloro-2,6-dimethoxypyrimidine
Similarity: 0.80
[ 186435-66-5 ]
6-Amino-2-methoxypyrimidin-4-ol
Similarity: 0.85
[ 60186-89-2 ]
4-Bromo-2,6-dimethoxypyrimidine
Similarity: 0.83
[ 120129-83-1 ]
2,4-Dimethoxy-5,6-dimethylpyrimidine
Similarity: 0.80
[ 6320-15-6 ]
4-Chloro-2,6-dimethoxypyrimidine
Similarity: 0.80